Diffuse large B-cell lymphoma (DLBCL) is the most frequent subtype of non-Hodgkin's lymphoma, which accounts for the majority of lymphomas. In addition, the number of B-cell lymphoma patients in Korea is increasing due to the westernization of lifestyle and population aging.DLBCL is characterized by
DongKoo Bio & Pharma, a Korean company known for its dermatological products, has announced a strategic investment of 10 billion won ($7.2 million) into Qurient, a local biotech, becoming its largest shareholder.Through this latest investment, DongKoo will acquire approximately 2.56 million new shar
We inhabit a plastic-laden world where plastic fragments into minuscule pieces, rather than decomposing. These plastic particles have been discovered by scientists in various human organs such as the lungs, liver, placenta, breast milk, and blood. How harmful are these microplastics to our health? A
CHA Bundang Medical Center (CBMC) has signed an agreement with Rutgers University, a prestigious public university in the United States, for joint research and technology development.Rutgers University Executive Vice President for Academic Affairs Prabhas V. Moghe, Professor Lee Ki-bum of the Depart
Handok said it finalized an exclusive distribution and supply agreement with Nxera Pharma Korea, the offshoot of a Japan-based pharmaceutical company Nxera, for Pivlaz, a drug designed to prevent cerebral vasospasm, vasospasm-related cerebral infarction, and cerebral ischemic symptoms after aneurysm
Pharmaceutical products are difficult to develop, manufacture, and produce, as they are directly linked to human lives. Moreover, the importance of drug distribution management has been emphasized recently. That’s because, unlike in the past, when synthetic chemical drugs were the mainstay, biologic
Yuyu Pharma said its contract manufacturing organization (CMO) business, a new growth engine, is on a roll with a series of contract signings.This month, the company signed new CMO agreements with 10 pharmaceutical companies for manufacturing Fexogien Tab. (fexofenadine hydrochloride), an antihistam
A patient with an aortic dissection who was transferred from Busan to Ulsan died a few days after surgery. The bereaved family filed a complaint with the Anti-Corruption and Civil Rights Commission (ACRC), claiming that the patient was not operated on in time due to the crippled operation of the eme
Lunit, a Korean medical AI company, has moved closer to acquiring Volpara Health Technologies, a New Zealand company specializing in AI-powered cancer examining software.Volpara said its shareholders approved the deal with 96.92 percent of the votes cast at the company's annual general meeting last
Unlike many other global pharmaceutical giants choosing to divest and spin-off units, Bristol Myers Squibb (BMS) is aggressively expanding its pipeline through open innovation and strategic acquisitions.As a leading biopharma company, BMS is enhancing its presence across multiple therapeutic areas,
OliX Pharmaceuticals, a Korean biotech firm specializing in RNA interference technologies, recently announced the promising results of its hair loss treatment, OLX104C, at the 13th World Congress for Hair Research (WCHR 2024) held in Texas, the U.S. from April 6-9.The WCHR, hosted by the Internation
Amyotrophic lateral sclerosis (ALS), more commonly known as Lou Gehrig's disease, is a rare disorder first recognized in the 1930s when the famous New York Yankees baseball player Lou Gehrig died of the disease at the young age of 38. A neurodegenerative disease that selectively destroys motor nerve
A technology that sequentially releases antibiotics and growth agents to enhance bone regeneration has been developed by a collaborative research team from Yonsei University.Patients suffering from chronic inflammatory bone diseases such as periodontal disease or osteoporosis experience slow bone re
PharmaEssentia Korea said it hosted a myeloproliferative neoplasms (MPN) forum to share the latest insights on Besremi (ropeginterferon alfa-2b), a treatment for polycythemia vera (PV) on Thursday last week.The forum featured two world-renowned experts in the field of MPN -- Professor Hans Carl Hass
Samsung Bioepis has achieved a significant milestone by obtaining the first domestic approval for a biosimilar referencing Janssen's Stelara, Epyztek (ingredient: ustekinumab), on Thursday.Stelara, originally developed by Janssen, is utilized in the treatment of plaque psoriasis, psoriatic arthritis
"I will humbly accept the people's will expressed in the parliamentary election and do my best to renew the state administration and stabilize the economy and people's livelihood."President Yoon Suk Yeol conveyed this message through his chief of staff in response to the general election results, wh
Janssen's Rybrevant (amivantamab), a treatment for EGFR exon20 insertion non-small cell lung cancer (NSCLC), a rare form of lung cancer with a poor prognosis, is making its third attempt to get reimbursement in Korea.The drug’s third challenge for insurance coverage comes when the “nominality” of th
Celltrion said Yuflyma (ingredient: adalimumab), a biosimilar referencing Humira, has been included in the formulary of one of the top three pharmacy benefit managers (PBMs) in the U.S. The three largest PBMs in the U.S., which include CVS Health, Express Scripts, and Optum, collectively manage abou
A Seoul court has rejected a request for an enforcement halt of the medical license suspension filed by Kim Taek-woo, chairman of the emergency committee of the Korean Medical Association (KMA), a group of some 130,000 Korean physicians.As things stand now, Kim's license will be suspended from next
NKMAX, a local biotech firm specializing in NK cell therapy, announced plans to file an objection to its potential delisting from the Korea Exchange (KRX).The company, which has been listed on the Kosdaq since August 2018, is facing delisting due to significant operational challenges.On March 5, NKM